“PHYSIO CONTROL LIFEPAK CR2 Defibrillator 3321605-xxx The LIFEPAK CR2 defibrillator is.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/63424-physio-control. Based on FDA recall #Z-1189-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1189-2021%22&limit=1).
The U.S. Food and Drug Administration (FDA) has classified a voluntary recall initiated by Physio-Control, Inc. as Class II.
How to tell if you have it
Physio-Control, Inc.
Class II
Voluntary: Firm initiated
The hazard
The provided facts do not describe the specific hazard associated with this particular recall; they only list hazards from other recent recalls by Physio-Control, Inc. and similar products.
Context
Physio-Control, Inc. has 17 other recalls on record since 2017-10-27. Recent recalls by Physio-Control, Inc. include issues with LIFEPAK 15 Defibrillators serviced between July 2023 through November 2025, Infant/Child Defibrillator Electrodes, and LIFEPAK 1000 Defibrillator inspections.
How to tell if you have this one
Check for the product's model number and serial number on the device itself or in the documentation.
Brand
Physio-Control
Category
Medical device
Based on the official FDA remedy
What to do — step by step
1
Identify the specific model of the Physio-Control device you have.
2
Check the device's model number and serial number, which are typically found on a label on the device or in the user manual.
3
Ensure that the device is being used in a medical setting with proper training and supervision.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 50 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide Distribution to U.S.(nationwide): AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, Guam, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI , SC, SD, TN, TX,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Recall timeline
FDA published this recall 2 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1189-2021 (January 14, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1189-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.